The Market Report for Radiopharmaceuticals: Forecasts to 2026

The Radiopharmaceuticals Market size is projected to reach USD 9.54 billion by 2026. According to a report published by Fortune Business Insights, titled “Radiopharmaceuticals Market Size, Share & Industry Analysis, By Type (PET Radiopharmaceuticals, SPECT Radiopharmaceuticals), By Application (Neurology, Cardiology, Oncology, and Others), By End User (Hospitals & Clinics, Diagnostic Centres, and Others) and Regional Forecast, 2019-2026,” the market was valued at USD 4.86 billion in 2018. Driven by increasing number of successful clinical trials, the market will exhibit a CAGR of 9.0% from 2019-2026.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nuclear-medicine-radiopharmaceuticals-market-101812

Leading Players operating in the Radiopharmaceuticals Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Lantheus Medical Imaging, Inc.
• Cardinal Health
• Norgine B.V.
• Curium
• Advanced Accelerator Applications (Novartis AG)
• Bracco Diagnostic Inc.
• Jubilant Life Sciences Limited
• GE Healthcare (General Electric Company)

Key Industry Developements:

• October 2019: Fuzionaire Diagnostics announces a partnership with Japan Medical Isotope Technology Development K.K. for the launch of Fuzionaire Radioisotope Technologies K.K., specializing in diagnostic radiopharmaceuticals.
• October 2019: GE Healthcare and Theragnostics announced a global commercial partnership for Theragnostics’ novel PET tracer called the GalliProst, a late-stage prostate-specific membrane antigen (PSMA) PET/CT imaging agent.

• Introduction
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions
• Executive Summary
• Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
• Key Insights
o Installed Base of PET/PET-CT Scanners – For Key Countries, 2015 and 2018
o Installed Base of Gamma Cameras – For Key Countries, 2018
o Reimbursement Scenario- For Key Countries
o New Product Launches
o Key Industry Developments
o Pipeline Analysis
• Global Radiopharmaceuticals Market Analysis, Insights and Forecast, 2015-2026
o Key Findings / Summary
o Market Analysis, Insights and Forecast – By Type
 PET Radiopharmaceuticals
• FDG-PET/18F
• 68Ga
• 68Cu
• 11C
• Others
 SPECT Radiopharmaceuticals
• Technetium-99m
• Iodine-123
• Xenon-133
• Thallium-201
• Others
o Market Analysis, Insights and Forecast – By Application
 Neurology
 Cardiology
 Oncology
 Others
o Market Analysis, Insights and Forecast – By End User
 Hospitals & Clinics
 Diagnostic Centers
 Others
o Market Analysis, Insights and Forecast – By Region
 North America
 Europe
 Asia Pacific
 Rest of the World
• North America Radiopharmaceuticals Market Analysis, Insights and Forecast, 2015-2026
o Key Findings / Summary
o Market Analysis – By Type
 PET Radiopharmaceuticals
• FDG-PET/18F
• 68Ga
• 68Cu
• 11C
• Others
 SPECT Radiopharmaceuticals
• Technetium-99m
• Iodine-123
• Xenon-133
• Thallium-201
• Others
o Market Analysis – By Application
 Neurology
 Cardiology
 Oncology
 Others
o Market Analysis – By End User
 Hospitals & Clinics
 Diagnostic Centers
 Others
o Market Analysis – By Country
 U.S.
 Canada
Report Focus:
• Latest technological developments
• Value chain analysis
• Potential Radiopharmaceuticals Market opportunities
• Growth dynamics
• Quality assurance
• Post-sales support
• Regular report updates

Reasons to Purchase this Report:

• Comprehensive analysis of the Radiopharmaceuticals Market growth drivers, obstacles, opportunities, and other related challenges.
• Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
• Identifies market restraints and boosters.
• Identifies all the possible segments present in the market to aid organizations in strategic business planning.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/nuclear-medicine-radiopharmaceuticals-market-101812

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.